speb/financial-data huggingface dataset:
Financial ratios for EQS.PA — annual report dated 2022-12-31
Total revenue: 227737234.04255322
Gross profit: 154872340.42553192
Operating income: 59822340.42553192
Net income: 51808510.63829788
Capital expenditures: 10878723.40425532
Operating cash flow: 60613829.787234046
Depreciation & amortization: 14843617.021276597
Net tangible assets: 72608510.63829787
Owner earnings: 55773404.25531916
Return on net tangible assets (%): 76.81386626032939
Capex to operating income (%): 18.185051482225738
Buffett classification: The Great
Stock price: 71.62765957446808
P/E ratio: 20.782713771252563
Shares outstanding: 15032202
Book value: 209358510.6382979
P/B ratio: 5.142955231329745
Market cap (USD): 1076721447.5106382
Debt to equity: 0.33799295720971356
Current ratio: 1.397699252104094
Quick ratio: 1.3028265166799127
Effective tax rate (%): 11.362215438932
Interest coverage ratio: 82.81737849779087
COGS to revenue (%): 31.995160529352134
Free cash flow (dilution-adjusted): 49360638.29787235
Buyback yield (%): 0.7192836057059513
Retained earnings: 49336170.21276596
Inventory turnover: 7.356137901406938
Receivables turnover: 4.600949965612105
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.25551114101397
FCF margin (%): 21.674382103301213
Revenue growth (%): 3.8016284113176284
Rule of 40 score: 25.476010514618842
Financial ratios for EQS.PA — annual report dated 2023-12-31
Total revenue: 244208888.8888889
Gross profit: 167382222.2222222
Operating income: 61955555.55555555
Net income: 54313333.33333333
Capital expenditures: 16277777.777777778
Operating cash flow: 64135555.55555555
Depreciation & amortization: 15083333.333333332
Net tangible assets: 98851111.1111111
Owner earnings: 53118888.88888888
Return on net tangible assets (%): 53.736258795494905
Capex to operating income (%): 26.273314203730276
Buffett classification: The Good
Stock price: 62.03333333333333
P/E ratio: 17.16885229041365
Shares outstanding: 15032202
Book value: 252917777.7777778
P/B ratio: 3.6869594758946693
Market cap (USD): 932497597.4
Debt to equity: 0.29004155940006854
Current ratio: 1.2230422076721046
Quick ratio: 1.1276587874079829
Effective tax rate (%): 16.899789231653575
Interest coverage ratio: 83.34828101644244
COGS to revenue (%): 31.459406337015672
Free cash flow (dilution-adjusted): 47466666.666666664
Buyback yield (%): 0.6150745665777042
Retained earnings: 52274444.44444444
Inventory turnover: 6.70389761489238
Receivables turnover: 4.161626872171625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.50243605572324
FCF margin (%): 19.436911933317557
Revenue growth (%): 7.23274563142271
Rule of 40 score: 26.669657564740266
Financial ratios for EQS.PA — annual report dated 2024-12-31
Capital expenditures: 0
Operating cash flow: 49535416.66666667
Depreciation & amortization: 16436458.333333334
Buffett classification: The Gruesome
Stock price: 43.09375
Shares outstanding: 15032202
Market cap (USD): 647793954.9375
Free cash flow (dilution-adjusted): 37405208.333333336
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAL.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.39370078740157477
Shares outstanding: 829625590
Market cap (USD): 326624248.03149605
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAL.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -668295.5882352941
Operating income: -3543744.117647059
Net income: -12230837.5
Capital expenditures: 8514455.88235294
Operating cash flow: 132358.0882352941
Depreciation & amortization: 459279.41176470584
Net tangible assets: 10819846.323529411
Owner earnings: -20286013.970588237
Return on net tangible assets (%): -187.4889288073639
Buffett classification: The Gruesome
Stock price: 0.36029411764705876
Shares outstanding: 829625590
Book value: 10819846.32352941
P/B ratio: 27.626013437588924
Market cap (USD): 298909219.9264705
Debt to equity: 0.32866258633797335
Current ratio: 0.21007887633138458
Quick ratio: 0.20411634197994646
Interest coverage ratio: -3.233085057212183
Free cash flow (dilution-adjusted): -9463287.5
Buyback yield (%): 0
Retained earnings: -51811889.70588235
Inventory turnover: 10.918550731601835
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.417895217061645
Rule of 40 score: 0
Financial ratios for GAL.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -528256.0606060605
Operating income: -2372946.9696969697
Net income: -6491015.151515151
Capital expenditures: 2910705.3030303027
Operating cash flow: -987463.6363636364
Depreciation & amortization: 390153.78787878784
Net tangible assets: 8603906.06060606
Owner earnings: -9011566.666666666
Return on net tangible assets (%): -104.73808759869108
Buffett classification: The Gruesome
Stock price: 0.17424242424242425
Shares outstanding: 829625590
Book value: 8603906.06060606
P/B ratio: 16.80120319734976
Market cap (USD): 144555974.01515153
Debt to equity: 0.7081717465182304
Current ratio: 0.25037888561905297
Quick ratio: 0.24929700973527658
Interest coverage ratio: -1.7319679405479083
Free cash flow (dilution-adjusted): -4166132.575757575
Buyback yield (%): 0
Retained earnings: -59872962.12121212
Inventory turnover: 38.34678838539375
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.854557910611543
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08888888888888888
Shares outstanding: 829625590
Market cap (USD): 73744496.88888888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 829625590
Market cap (USD): 29007887.762237765
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GAL.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -382853.14685314684
Operating income: -1797612.5874125876
Net income: -1041037.7622377623
Capital expenditures: 874528.6713286714
Operating cash flow: -1334462.937062937
Depreciation & amortization: 304134.26573426573
Net tangible assets: 7978817.482517483
Owner earnings: -1611432.1678321678
Return on net tangible assets (%): -20.196378365127455
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 829625590
Book value: 7978817.482517485
P/B ratio: 3.635612398177727
Market cap (USD): 29007887.762237765
Debt to equity: 0.574611937955648
Current ratio: 0.06371137373599643
Quick ratio: 0.05137814756494638
Interest coverage ratio: -0.9930747858228975
Free cash flow (dilution-adjusted): -2511082.5174825178
Buyback yield (%): 0
Retained earnings: -56308387.41258741
Inventory turnover: 2.5625807417947613
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.705746794519419
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -73235.66433566433
Operating income: -342046.85314685316
Net income: -856724.4755244756
Capital expenditures: 179964.33566433567
Operating cash flow: -341928.67132867133
Depreciation & amortization: 62791.608391608395
Net tangible assets: 7463437.762237762
Owner earnings: -973897.2027972029
Return on net tangible assets (%): -13.048909012476301
Buffett classification: The Gruesome
Stock price: 0.06293706293706294
Shares outstanding: 829625590
Book value: 7463437.762237761
P/B ratio: 6.9959983100833965
Market cap (USD): 52214197.97202798
Debt to equity: 0.6564203526075276
Current ratio: 0.08493577298760675
Quick ratio: 0.059604801179604365
Interest coverage ratio: -0.6956838973215301
Free cash flow (dilution-adjusted): -571874.1258741259
Buyback yield (%): 0
Retained earnings: -57165111.88811189
Inventory turnover: 0.21900113550103198
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.593954462834996
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -79032.11678832116
Operating income: -499428.46715328464
Net income: -518273.7226277372
Capital expenditures: 476884.6715328467
Operating cash flow: 121372.99270072991
Depreciation & amortization: 68469.34306569342
Net tangible assets: 7443464.233576641
Owner earnings: -926689.0510948906
Return on net tangible assets (%): -12.449701133978706
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
Shares outstanding: 829625590
Book value: 7443464.233576644
P/B ratio: 6.508433225013153
Market cap (USD): 48445289.927007295
Debt to equity: 0.6943734306273291
Current ratio: 0.04443982248581496
Quick ratio: 0.03161104803669057
Interest coverage ratio: -0.980151073025314
Free cash flow (dilution-adjusted): -384301.45985401457
Buyback yield (%): 0
Retained earnings: -60186967.15328467
Inventory turnover: 0.4356927286628305
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.715476306580324
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -76363.30935251799
Operating income: -502537.4100719425
Net income: -3600494.244604317
Capital expenditures: 405502.1582733813
Operating cash flow: 214412.23021582735
Depreciation & amortization: 65162.58992805756
Net tangible assets: 2903276.258992806
Owner earnings: -3940833.8129496407
Return on net tangible assets (%): -135.737472475898
Buffett classification: The Gruesome
Stock price: 0.05755395683453238
Shares outstanding: 829625590
Book value: 2903276.2589928056
P/B ratio: 16.446328608166315
Market cap (USD): 47748235.39568345
Debt to equity: 0.2682300868728309
Current ratio: 0.07570098625402356
Quick ratio: 0.07570098625402356
Interest coverage ratio: -0.5976047115267804
Free cash flow (dilution-adjusted): -208610.7913669065
Buyback yield (%): 0
Retained earnings: -62921461.870503604
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.493814334609707
Rule of 40 score: 0
Financial ratios for GAL.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -232953.28467153283
Operating income: -1733640.8759124086
Net income: -6199473.722627737
Capital expenditures: 1180778.102189781
Operating cash flow: -502129.9270072992
Depreciation & amortization: 200124.81751824816
Net tangible assets: 18441711.678832114
Owner earnings: -7180127.00729927
Return on net tangible assets (%): -38.93416800101484
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 829625590
Book value: 18441711.678832114
P/B ratio: 4.268779249040526
Market cap (USD): 78723596.13138686
Debt to equity: 0.03597509533390764
Current ratio: 2.4750927677857764
Quick ratio: 2.4750927677857764
Interest coverage ratio: -1.0763188269057955
Free cash flow (dilution-adjusted): -1799421.1678832115
Buyback yield (%): 0
Retained earnings: -64973921.89781021
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.400650580077812
Rule of 40 score: 0
Financial ratios for GAL.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: 0
Operating income: -367311.67883211677
Net income: -1133898.5401459853
Capital expenditures: 104625.54744525546
Operating cash flow: -484141.60583941604
Depreciation & amortization: 0
Net tangible assets: 18441711.678832114
Owner earnings: -1238524.0875912409
Return on net tangible assets (%): -6.715884670363065
Buffett classification: The Gruesome
Stock price: 0.0948905109489051
Shares outstanding: 829625590
Book value: 18441711.678832114
P/B ratio: 4.268779249040526
Market cap (USD): 78723596.13138686
Debt to equity: 0.03597509533390764
Current ratio: 2.4750927677857764
Quick ratio: 2.4750927677857764
Free cash flow (dilution-adjusted): -606543.795620438
Buyback yield (%): 0
Retained earnings: -64973921.89781021
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.991743961888998
Rule of 40 score: 0
Financial ratios for GS71.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.18181818181818
Shares outstanding: 4005595364
Market cap (USD): 76834601982.18181
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GS71.DE — annual report dated 2022-12-31
Total revenue: 35330120481.92771
Gross profit: 23819277108.433735
Operating income: 8107228915.662651
Net income: 18820481927.710846
Capital expenditures: 1201204819.2771084
Operating cash flow: 8919277108.433735
Depreciation & amortization: 2586746987.9518075
Net tangible assets: -12971084337.349398
Owner earnings: 20206024096.385548
Return on net tangible assets (%): -155.7774475199703
Capex to operating income (%): 14.816466042502599
Buffett classification: The Great
Stock price: 15.563829787234043
P/E ratio: 3.3124765179385904
Shares outstanding: 4005595364
Book value: 12163855421.686737
P/B ratio: 5.125217480855663
Market cap (USD): 62342404441.82979
Debt to equity: 2.0787440570522997
Current ratio: 0.9105217010083296
Quick ratio: 0.684918895221394
Effective tax rate (%): 12.56218905472637
Interest coverage ratio: 8.146489104116224
COGS to revenue (%): 32.580821170372396
R&D to revenue (%): 18.715045696357933
SG&A to revenue (%): 28.54999317964807
Free cash flow (dilution-adjusted): 5781927710.843373
Buyback yield (%): 0
Retained earnings: 5256626506.0240965
Inventory turnover: 1.8565876408861253
Receivables turnover: 5.378576669112252
Capitalized R&D asset: 6612048192.771085
ROCI (R&D-adjusted, %): 24.256647362849492
FCF margin (%): 16.36543445641795
Rule of 40 score: 16.36543445641795
Financial ratios for GS71.DE — annual report dated 2023-12-31
Total revenue: 38389873417.72152
Gross profit: 27548101265.822784
Operating income: 9297468354.43038
Net income: 6718987341.772152
Capital expenditures: 1627848101.2658226
Operating cash flow: 8567088607.594936
Depreciation & amortization: 2903797468.35443
Net tangible assets: -10420253164.556961
Owner earnings: 7994936708.860761
Return on net tangible assets (%): -76.72497570456756
Capex to operating income (%): 17.508509189925118
Buffett classification: The Great
Stock price: 17.08888888888889
P/E ratio: 10.187721843689358
Shares outstanding: 4005595364
Book value: 16196202531.645569
P/B ratio: 4.226371828550458
Market cap (USD): 68451174109.244446
Debt to equity: 1.4082063305978898
Current ratio: 0.8849439908866528
Quick ratio: 0.6239794949686729
Effective tax rate (%): 12.467018469656992
Interest coverage ratio: 10.13103448275862
COGS to revenue (%): 28.241229227116854
R&D to revenue (%): 20.518992350303346
SG&A to revenue (%): 30.945001318913214
Free cash flow (dilution-adjusted): 5211392405.063292
Buyback yield (%): 0
Retained earnings: 9163291139.240505
Inventory turnover: 1.5578392142597306
Receivables turnover: 5.135986452159187
Capitalized R&D asset: 12307287479.030045
ROCI (R&D-adjusted, %): 20.46274376454563
Rosenberg metric: 0.5639438867771339
FCF margin (%): 13.574914270640992
Revenue growth (%): 8.660465614202908
Rule of 40 score: 22.2353798848439
Financial ratios for GS71.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.11111111111111
Shares outstanding: 4005595364
Market cap (USD): 76551378067.55556
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GS71.DE — annual report dated 2024-12-31
Total revenue: 39220000000
Gross profit: 27910000000
Operating income: 6927500000
Net income: 3688750000
Capital expenditures: 1667500000
Operating cash flow: 8192500000
Depreciation & amortization: 3188750000
Net tangible assets: -11032500000
Owner earnings: 5210000000
Return on net tangible assets (%): -47.22411058237027
Capex to operating income (%): 24.070732587513533
Buffett classification: The Great
Stock price: 16.1875
P/E ratio: 17.577926114469673
Shares outstanding: 4005595364
Book value: 16357500000
P/B ratio: 3.963966067843497
Market cap (USD): 64840574954.75
Debt to equity: 1.2980284273269143
Current ratio: 0.7833801908097894
Quick ratio: 0.522099829469512
Effective tax rate (%): 15.127983894161634
Interest coverage ratio: 8.659375
COGS to revenue (%): 28.83732789393167
R&D to revenue (%): 20.400943396226413
SG&A to revenue (%): 35.10645079041305
Free cash flow (dilution-adjusted): 4035000000
Buyback yield (%): 0
Retained earnings: 9745000000
Inventory turnover: 1.5960486858352443
Receivables turnover: 5.640122236203488
Capitalized R&D asset: 15460960080.829649
ROCI (R&D-adjusted, %): 11.859094983664034
Rosenberg metric: 0.04594247147677974
FCF margin (%): 10.288118306986231
Revenue growth (%): 2.162358216829331
Rule of 40 score: 12.450476523815562
Financial ratios for GS71.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.1875
Shares outstanding: 4005595364
Market cap (USD): 64840574954.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GS71.DE — quarterly report dated 2025-03-31
Total revenue: 9761038961.038961
Gross profit: 7245454545.454545
Operating income: 2877922077.9220777
Net income: 2301298701.2987013
Capital expenditures: 268831168.83116883
Operating cash flow: 1487012987.012987
Depreciation & amortization: 1068831168.8311688
Net tangible assets: -11723376623.376623
Owner earnings: 3101298701.2987013
Return on net tangible assets (%): -26.453971419076105
Capex to operating income (%): 9.341155234657041
Buffett classification: The Great
Stock price: 18.3695652173913
P/E ratio: 7.993426193648173
Shares outstanding: 4005595364
Book value: 17732467532.467537
P/B ratio: 4.149509657285647
Market cap (USD): 73581045273.47824
Debt to equity: 1.3499340852497435
Current ratio: 0.8681772358504152
Quick ratio: 0.5801449762373385
Effective tax rate (%): 15.939278937381404
Interest coverage ratio: 13.679012345679011
COGS to revenue (%): 25.771687067589138
R&D to revenue (%): 19.451836083022883
SG&A to revenue (%): 27.541245343267697
Free cash flow (dilution-adjusted): 905194805.1948051
Buyback yield (%): 0.43595360678416906
Retained earnings: 10788311688.311687
Inventory turnover: 0.3228333333333333
Receivables turnover: 1.0647400481654627
Capitalized R&D asset: 1898701298.7012987
ROCI (R&D-adjusted, %): 7.718856847945293
FCF margin (%): 9.273549760510909
Rule of 40 score: 9.273549760510909
Financial ratios for GS71.DE — quarterly report dated 2025-06-30
Total revenue: 10939726027.39726
Gross profit: 7973972602.739726
Operating income: 2771232876.712329
Net income: 2254794520.547945
Capital expenditures: 343835616.43835616
Operating cash flow: 2871232876.712329
Depreciation & amortization: 1587671232.8767123
Net tangible assets: -10026027397.260275
Owner earnings: 3498630136.9863014
Return on net tangible assets (%): -34.895477524251945
Capex to operating income (%): 12.40731586752348
Buffett classification: The Great
Stock price: 18.611764705882354
P/E ratio: 16.3629659867944
Shares outstanding: 4005595364
Book value: 19663013698.630142
P/B ratio: 3.791443141136342
Market cap (USD): 74551198421.74118
Debt to equity: 1.2090009753378845
Current ratio: 0.8672588085189911
Quick ratio: 0.5692904112277947
Effective tax rate (%): 12.7715951245363
Interest coverage ratio: 10.994565217391305
COGS to revenue (%): 27.109942399198594
R&D to revenue (%): 25.344352617079892
SG&A to revenue (%): 26.79689456548961
Free cash flow (dilution-adjusted): 2004109589.041096
Buyback yield (%): 1.0308260188354232
Retained earnings: 12050684931.50685
Inventory turnover: 0.3565546772068511
Receivables turnover: 1.0908345854391477
Capitalized R&D asset: 4044732609.855898
ROCI (R&D-adjusted, %): 6.957043560511996
Rosenberg metric: 0.3836928208683922
FCF margin (%): 18.319559228650135
Revenue growth (%): 12.075426305160862
Rule of 40 score: 30.394985533810996
Financial ratios for GS71.DE — quarterly report dated 2025-09-30
Total revenue: 11550000000
Gross profit: 8498648648.648649
Operating income: 3504054054.0540543
Net income: 2897297297.2972975
Capital expenditures: 413513513.5135135
Operating cash flow: 3002702702.7027025
Depreciation & amortization: 997297297.2972974
Net tangible assets: -10586486486.486486
Owner earnings: 3481081081.0810814
Return on net tangible assets (%): -32.88230788869033
Capex to operating income (%): 11.801002699575779
Buffett classification: The Great
Stock price: 20.870588235294118
P/E ratio: 11.216255375929075
Shares outstanding: 4005595364
Book value: 21286486486.48649
P/B ratio: 3.9273335001677765
Market cap (USD): 83599131479.24706
Debt to equity: 1.1268410360589132
Current ratio: 0.836317615074529
Quick ratio: 0.5495453267085404
Effective tax rate (%): 12.703583061889251
Interest coverage ratio: 15.52694610778443
COGS to revenue (%): 26.418626418626417
R&D to revenue (%): 19.76131976131976
SG&A to revenue (%): 26.196326196326197
Free cash flow (dilution-adjusted): 1814864864.8648648
Buyback yield (%): 0.5124196517337272
Retained earnings: 13535135135.135136
Inventory turnover: 0.36907486106570775
Receivables turnover: 1.0768552349754315
Capitalized R&D asset: 4766647696.620299
ROCI (R&D-adjusted, %): 5.896182526897845
Rosenberg metric: 0.18923592564896932
FCF margin (%): 15.713115713115714
Revenue growth (%): 5.578512396694211
Rule of 40 score: 21.291628109809924
Financial ratios for GS71.DE — quarterly report dated 2025-12-31
Total revenue: 11645945945.945946
Gross profit: 8055405405.405405
Operating income: 2035135135.1351352
Net income: 982432432.4324324
Capital expenditures: 756756756.7567568
Operating cash flow: 3078378378.3783784
Depreciation & amortization: -548648648.6486486
Net tangible assets: -9985135135.135136
Owner earnings: -322972972.972973
Capex to operating income (%): 37.18459495351926
Buffett classification: The Good
Stock price: 24.38823529411765
P/E ratio: 11.580304943693006
Shares outstanding: 4005595364
Book value: 21562162162.162163
P/B ratio: 4.530593986612656
Market cap (USD): 97689402230.25883
Debt to equity: 1.1105540235648033
Current ratio: 0.8185685568697116
Quick ratio: 0.5416296573325231
Effective tax rate (%): 23.473684210526315
Interest coverage ratio: 8.655172413793103
COGS to revenue (%): 30.830819215595266
R&D to revenue (%): 27.268507774425622
SG&A to revenue (%): 30.621954049663497
Free cash flow (dilution-adjusted): 1693243243.2432432
Buyback yield (%): 0.3485951728293611
Retained earnings: 13795945945.945946
Inventory turnover: 0.44851451721809593
Receivables turnover: 1.4574665990191105
Capitalized R&D asset: 5619864309.514996
ROCI (R&D-adjusted, %): 4.1602572317737385
Rosenberg metric: -0.19419775014801696
FCF margin (%): 14.53933627291715
Revenue growth (%): 0.830700830700829
Rule of 40 score: 15.37003710361798
Financial ratios for GS71.DE — annual report dated 2025-12-31
Total revenue: 44144594594.5946
Gross profit: 31959459459.45946
Operating income: 11267567567.567568
Net income: 8498648648.648649
Capital expenditures: 1789189189.1891892
Operating cash flow: 10460810810.81081
Depreciation & amortization: 3127027027.027027
Net tangible assets: -9985135135.135136
Owner earnings: 9836486486.486486
Return on net tangible assets (%): -98.51130058194613
Capex to operating income (%): 15.879107699688175
Buffett classification: The Great
Stock price: 24.38823529411765
P/E ratio: 11.494698306629278
Shares outstanding: 4005595364
Book value: 21562162162.162163
P/B ratio: 4.530593986612656
Market cap (USD): 97689402230.25883
Debt to equity: 1.1105540235648033
Current ratio: 0.8185685568697116
Quick ratio: 0.5416296573325231
Effective tax rate (%): 15.024996622078099
Interest coverage ratio: 12.136826783114993
COGS to revenue (%): 27.602779563473838
R&D to revenue (%): 23.035479229803776
SG&A to revenue (%): 27.820124284446074
Free cash flow (dilution-adjusted): 5921621621.621622
Buyback yield (%): 1.9048236229604376
Retained earnings: 13795945945.945946
Inventory turnover: 1.522113436866982
Receivables turnover: 5.524606798579401
Capitalized R&D asset: 18129237431.57715
ROCI (R&D-adjusted, %): 17.759711128912443
Rosenberg metric: 0.506103353783404
FCF margin (%): 13.414148835215967
Revenue growth (%): 12.556335019364093
Rule of 40 score: 25.97048385458006
Financial ratios for GSRF — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -311977
Net income: 1913198
Capital expenditures: 0
Operating cash flow: -285924
Net tangible assets: 225365960
Owner earnings: 1913198
Return on net tangible assets (%): 0.8489294479077496
Buffett classification: The Gruesome
Stock price: 9.99
P/E ratio: 101.81799439807772
Shares outstanding: 23655500
Book value: 225365960
P/B ratio: 1.0485986659209758
Market cap (USD): 236318445
Debt to equity: 0
Current ratio: 81.28645933014354
Quick ratio: 81.28645933014354
Free cash flow (dilution-adjusted): -285924
Buyback yield (%): 0
Retained earnings: -7522654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.13300182174770797
Rule of 40 score: 0
Financial ratios for GSRF — annual report dated 2025-12-31
Total revenue: 0
Operating income: -567012
Net income: 2320989
Capital expenditures: 0
Operating cash flow: -611118
Net tangible assets: 225365960
Owner earnings: 2320989
Return on net tangible assets (%): 1.0298755854699617
Buffett classification: The Gruesome
Stock price: 9.99
P/E ratio: 101.81799439807772
Shares outstanding: 23655500
Book value: 225365960
P/B ratio: 1.0485986659209758
Market cap (USD): 236318445
Debt to equity: 0
Current ratio: 81.28645933014354
Quick ratio: 81.28645933014354
Free cash flow (dilution-adjusted): -611118
Buyback yield (%): 0
Retained earnings: -7522654
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2417281689124884
Rule of 40 score: 0
Financial ratios for GUG — annual report dated 2022-05-31
Capital expenditures: 0
Net tangible assets: 575323330
Buffett classification: The Gruesome
Stock price: 10.76
Shares outstanding: 32980083
Book value: 575323330
P/B ratio: 0.6168108862889324
Market cap (USD): 354865693.08
Debt to equity: 0.43138369514756164
Buyback yield (%): 0
Retained earnings: -84222694
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GUG — annual report dated 2023-05-31
Total revenue: -6129302
Net income: -7116471
Capital expenditures: 0
Operating cash flow: 99586854
Net tangible assets: 521215360
Owner earnings: -7116471
Return on net tangible assets (%): -1.3653609517570626
Buffett classification: The Gruesome
Stock price: 10.16
Shares outstanding: 32980083
Book value: 521215360
P/B ratio: 0.6428775300866038
Market cap (USD): 335077643.28000003
Debt to equity: 0.377022417374653
Free cash flow (dilution-adjusted): 99586854
Buyback yield (%): 0
Retained earnings: -127714419
Receivables turnover: -0.7340616820956938
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GUG — annual report dated 2024-05-31
Total revenue: 70155555
Net income: 69224874
Capital expenditures: 0
Operating cash flow: 78558820
Net tangible assets: 543443616
Owner earnings: 69224874
Return on net tangible assets (%): 12.738188831718652
Buffett classification: The Gruesome
Stock price: 12.4
P/E ratio: 5.907602362699858
Shares outstanding: 32980083
Book value: 543443616
P/B ratio: 0.7525215443877805
Market cap (USD): 408953029.2
Debt to equity: 0.3062346710868345
COGS to revenue (%): 0
SG&A to revenue (%): 1.3559496464677672
Free cash flow (dilution-adjusted): 78558820
Buyback yield (%): 0
Retained earnings: -88331452
Receivables turnover: 7.223027577219788
Capitalized R&D asset: 0
FCF margin (%): 111.97804649966778
Rule of 40 score: 111.97804649966778
Financial ratios for GUG — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 561045803
Buffett classification: The Gruesome
Stock price: 13.59
Shares outstanding: 32980083
Book value: 561045803
P/B ratio: 0.798864059892094
Market cap (USD): 448199327.96999997
Debt to equity: 0.38098189106317937
Buyback yield (%): 0
Retained earnings: -70729265
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GUG — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 542389320
Buffett classification: The Gruesome
Stock price: 13.69
Shares outstanding: 32980083
Book value: 542389320
P/B ratio: 0.8324229840476948
Market cap (USD): 451497336.27
Debt to equity: 0.3364194542031174
Buyback yield (%): 0
Retained earnings: -72954174
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GUG — annual report dated 2025-05-31
Total revenue: 46971070
Net income: 45942322
Capital expenditures: 0
Operating cash flow: 31352928
Net tangible assets: 542389320
Owner earnings: 45942322
Return on net tangible assets (%): 8.47035889275991
Buffett classification: The Gruesome
Stock price: 13.69
P/E ratio: 9.827481864543111
Shares outstanding: 32980083
Book value: 542389320
P/B ratio: 0.8324229840476948
Market cap (USD): 451497336.27
Debt to equity: 0.3364194542031174
COGS to revenue (%): 0
SG&A to revenue (%): 2.182956445318363
Free cash flow (dilution-adjusted): 31352928
Buyback yield (%): 0
Retained earnings: -72954174
Receivables turnover: 1.7504822474323523
Capitalized R&D asset: 0
FCF margin (%): 66.74944385980562
Revenue growth (%): -33.04725477547715
Rule of 40 score: 33.702189084328474
Financial ratios for HAR.AX — annual report dated 2022-12-31
Operating income: -2684391.2162162163
Net income: -5127247.297297297
Capital expenditures: 49934.45945945946
Net tangible assets: 2201797.972972973
Owner earnings: -5177181.756756756
Return on net tangible assets (%): -235.13427754528627
Buffett classification: The Gruesome
Stock price: 0.08108108108108109
Shares outstanding: 453036975
Book value: 2294789.189189189
P/B ratio: 16.007016189439767
Market cap (USD): 36732727.7027027
Debt to equity: 0
Current ratio: 2.2104886123154865
Quick ratio: 2.2104886123154865
Free cash flow (dilution-adjusted): -2208250
Buyback yield (%): 0.8498202602557993
Retained earnings: -37821395.27027027
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -116.97768269357604
Rule of 40 score: 0
Financial ratios for HAR.AX — annual report dated 2023-12-31
Operating income: -2488945.205479452
Net income: -2342317.808219178
Capital expenditures: 0
Net tangible assets: 3009630.821917808
Owner earnings: -2342317.808219178
Return on net tangible assets (%): -77.82741295580557
Buffett classification: The Gruesome
Stock price: 0.1232876712328767
Shares outstanding: 453036975
Book value: 2957059.5890410957
P/B ratio: 18.888315215943642
Market cap (USD): 55853873.63013698
Debt to equity: 0
Current ratio: 13.33919350522918
Quick ratio: 13.33919350522918
Free cash flow (dilution-adjusted): -2066977.397260274
Buyback yield (%): 0
Retained earnings: -40681814.38356165
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -84.16959924323196
Rule of 40 score: 0
Financial ratios for HAVA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -123.24902114875061
Net income: 574.3287132017998
Capital expenditures: 0
Operating cash flow: 455.9937687337872
Net tangible assets: 98954.9165107691
Owner earnings: 574.3287132017998
Return on net tangible assets (%): 0.5803943183957885
Buffett classification: The Gruesome
Stock price: 9.93
P/E ratio: 311755.5671080328
Shares outstanding: 15859856
Book value: 98954.91651076911
P/B ratio: 1591.5163756705385
Market cap (USD): 157488370.07999998
Debt to equity: 0.0023313939651410744
Current ratio: 2.340269484451684
Quick ratio: 2.340269484451684
Free cash flow (dilution-adjusted): 455.9937687337872
Buyback yield (%): 0
Retained earnings: -2583.8953759275614
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.12085590429521179
Rule of 40 score: 0
Financial ratios for HAVA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -190.50775083280593
Net income: 507.06998351774445
Capital expenditures: 0
Operating cash flow: -912.3470870916816
Net tangible assets: 98954.9165107691
Owner earnings: 507.06998351774445
Return on net tangible assets (%): 0.5124252552550644
Buffett classification: The Gruesome
Stock price: 9.93
P/E ratio: 310585.07740379556
Shares outstanding: 15859856
Book value: 98954.91651076911
P/B ratio: 1591.5163756705385
Market cap (USD): 157488370.07999998
Debt to equity: 0.0023313939651410744
Current ratio: 2.340269484451684
Quick ratio: 2.340269484451684
Free cash flow (dilution-adjusted): -912.3470870916816
Buyback yield (%): 0
Retained earnings: -2583.8953759275614
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.18680867634930537
Rule of 40 score: 0
Financial ratios for HC.V — annual report dated 2024-03-31
Total revenue: 2275634.814814815
Gross profit: 729457.037037037
Operating income: -6017268.148148147
Net income: -5926298.518518518
Capital expenditures: 139657.03703703702
Operating cash flow: -3956573.333333333
Depreciation & amortization: 186795.55555555553
Net tangible assets: 2596374.0740740737
Owner earnings: -5879159.999999999
Return on net tangible assets (%): -226.43732498741122
Buffett classification: The Gruesome
Stock price: 0.11764705882352941
Shares outstanding: 138565416
Book value: 2596374.0740740737
P/B ratio: 6.278684496906488
Market cap (USD): 16301813.647058824
Debt to equity: 0.07204605853462308
Current ratio: 2.502228872428875
Quick ratio: 2.1384062975350604
COGS to revenue (%): 67.94489905462277
R&D to revenue (%): 28.29702871677321
SG&A to revenue (%): 259.9710882466008
Free cash flow (dilution-adjusted): -5356433.333333333
Buyback yield (%): 0
Retained earnings: -16723123.703703703
Inventory turnover: 2.589629769316087
Receivables turnover: 2.0508372291430375
Capitalized R&D asset: 700790.3729148996
ROCI (R&D-adjusted, %): -160.25184205137367
Rosenberg metric: 7.0788560602955934
FCF margin (%): -235.38193819421002
Revenue growth (%): 515.6486556483666
Rule of 40 score: 280.26671745415655
Financial ratios for HC.V — quarterly report dated 2024-09-30
Capital expenditures: 26489.629629629628
Buffett classification: The Gruesome
Stock price: 0.08888888888888888
Shares outstanding: 138565416
Market cap (USD): 12316925.866666665
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HC.V — quarterly report dated 2024-12-31
Total revenue: 3481783.916083916
Gross profit: 747499.3006993007
Operating income: -237774.1258741259
Net income: -237220.27972027974
Capital expenditures: 5658.041958041958
Operating cash flow: 207004.1958041958
Depreciation & amortization: 47864.33566433567
Net tangible assets: 583146.8531468532
Owner earnings: -195013.98601398602
Return on net tangible assets (%): -33.44165967142344
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
Shares outstanding: 138565416
Book value: 583146.8531468529
P/B ratio: 13.293240532437949
Market cap (USD): 7751911.384615386
Debt to equity: 0.14612663388895555
Current ratio: 1.1581991874651485
Quick ratio: 1.0402686117392017
COGS to revenue (%): 78.53114039483418
R&D to revenue (%): 5.0174022600342925
SG&A to revenue (%): 21.905839201872045
Free cash flow (dilution-adjusted): 137472.027972028
Buyback yield (%): 0
Retained earnings: -17799421.67832168
Inventory turnover: 7.524680203299675
Receivables turnover: 1.9728509422942353
Capitalized R&D asset: 174695.10489510492
ROCI (R&D-adjusted, %): -13.611381373841363
FCF margin (%): 3.9483216444588436
Rule of 40 score: 3.9483216444588436
Financial ratios for HC.V — annual report dated 2025-03-31
Total revenue: 7031640.55944056
Gross profit: 1591309.090909091
Operating income: -3019446.153846154
Net income: -3003542.6573426574
Capital expenditures: 59631.468531468534
Operating cash flow: -1640945.4545454546
Depreciation & amortization: 193465.03496503498
Net tangible assets: 434641.95804195805
Owner earnings: -2869709.090909091
Return on net tangible assets (%): -660.2466784009988
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 138565416
Book value: 434641.95804195805
P/B ratio: 13.376374348792833
Market cap (USD): 5813933.538461539
Debt to equity: 0.08006911886320707
Current ratio: 1.1174282506653908
Quick ratio: 0.8547239556421162
COGS to revenue (%): 77.3693055346433
R&D to revenue (%): 7.524828333389358
SG&A to revenue (%): 55.29536522527644
Free cash flow (dilution-adjusted): -2030927.9720279723
Buyback yield (%): 0
Retained earnings: -18603930.06993007
Inventory turnover: 5.552198562933739
Receivables turnover: 3.5889892290126006
Capitalized R&D asset: 988559.085246673
ROCI (R&D-adjusted, %): -179.20070928363526
Rosenberg metric: 1.338410441240831
FCF margin (%): -28.88270461011098
Revenue growth (%): 208.99687918567798
Rule of 40 score: 180.114174575567
Financial ratios for HC.V — quarterly report dated 2025-03-31
Total revenue: 1957764.3356643356
Gross profit: 377649.65034965036
Operating income: -838379.020979021
Net income: -849738.4615384616
Capital expenditures: 948.2517482517483
Operating cash flow: -1079680.4195804195
Depreciation & amortization: 43778.32167832168
Net tangible assets: 434641.95804195805
Owner earnings: -806908.3916083917
Return on net tangible assets (%): -185.64898686805958
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 138565416
Book value: 434641.95804195805
P/B ratio: 13.376374348792833
Market cap (USD): 5813933.538461539
Debt to equity: 0.08006911886320707
Current ratio: 1.1174282506653908
Quick ratio: 0.8547239556421162
COGS to revenue (%): 80.71015783309277
R&D to revenue (%): 4.613761308299784
SG&A to revenue (%): 55.263228393454355
Free cash flow (dilution-adjusted): -1105106.9930069929
Buyback yield (%): 0
Retained earnings: -18603930.06993007
Inventory turnover: 1.6126058744436864
Receivables turnover: 0.9992540224785513
Capitalized R&D asset: 207372.29370629374
ROCI (R&D-adjusted, %): -99.27691591120501
Rosenberg metric: -2.1171151336594423
FCF margin (%): -56.447396291545616
Revenue growth (%): -43.771228116123254
Rule of 40 score: -100.21862440766887
Financial ratios for HC.V — quarterly report dated 2025-06-30
Total revenue: 2485096.3503649635
Gross profit: 614154.7445255474
Operating income: -304240.87591240875
Net income: -309975.1824817518
Capital expenditures: 0
Operating cash flow: -436561.3138686131
Depreciation & amortization: 35394.1605839416
Net tangible assets: 820989.7810218978
Owner earnings: -274581.02189781016
Return on net tangible assets (%): -33.4451205416997
Buffett classification: The Gruesome
Stock price: 0.0656934306569343
Shares outstanding: 138565416
Book value: 820989.7810218977
P/B ratio: 11.087638065500428
Market cap (USD): 9102837.547445254
Debt to equity: 0.015866552390029483
Current ratio: 1.2951138199331225
Quick ratio: 1.2177976640597326
COGS to revenue (%): 75.28648157101223
R&D to revenue (%): 5.680844226985868
SG&A to revenue (%): 29.85103604495353
Free cash flow (dilution-adjusted): -502320.43795620435
Buyback yield (%): 0
Retained earnings: -18601705.10948905
Inventory turnover: 8.32880584890333
Receivables turnover: 1.2473143728041092
Capitalized R&D asset: 259342.64136593335
ROCI (R&D-adjusted, %): -23.10663747524832
Rosenberg metric: 2.6183335114350625
FCF margin (%): -20.213318404432613
Revenue growth (%): 26.935418379745197
Rule of 40 score: 6.7220999753125845
Financial ratios for HC.V — quarterly report dated 2025-09-30
Total revenue: 2642169.784172662
Gross profit: 616202.8776978417
Operating income: -311449.6402877698
Net income: -303831.65467625903
Capital expenditures: 15653.956834532375
Operating cash flow: -225177.69784172662
Depreciation & amortization: 33100
Net tangible assets: 537576.9784172663
Owner earnings: -286385.6115107914
Return on net tangible assets (%): -53.27341441480022
Buffett classification: The Gruesome
Stock price: 0.06474820143884892
Shares outstanding: 138565416
Book value: 537576.9784172662
P/B ratio: 16.689445098710976
Market cap (USD): 8971861.4676259
Debt to equity: 0
Current ratio: 1.191302198668498
Quick ratio: 1.0894192422436768
COGS to revenue (%): 76.67814985285692
R&D to revenue (%): 5.740376886666072
SG&A to revenue (%): 29.369119995120645
Free cash flow (dilution-adjusted): -278564.02877697843
Buyback yield (%): 0
Retained earnings: -18637886.330935255
Inventory turnover: 6.5435166510209966
Receivables turnover: 1.1248720106073076
Capitalized R&D asset: 276065.1560395704
ROCI (R&D-adjusted, %): -28.51740787099381
Rosenberg metric: 0.014507817351019189
FCF margin (%): -10.543002589979459
Revenue growth (%): 6.320617459545606
Rule of 40 score: -4.222385130433852
Financial ratios for HCAT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.62
Shares outstanding: 73894020
Market cap (USD): 2927681072.3999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCAT — annual report dated 2022-12-31
Total revenue: 276236000
Gross profit: 133187000
Operating income: -140005000
Net income: -137403000
Capital expenditures: 2138000
Operating cash flow: -35270000
Depreciation & amortization: 48297000
Net tangible assets: 146839000
Owner earnings: -91244000
Return on net tangible assets (%): -62.13880508584232
Buffett classification: The Gruesome
Stock price: 10.63
Shares outstanding: 73894020
Book value: 425010000
P/B ratio: 1.8481763549092962
Market cap (USD): 785493432.6
Debt to equity: 0.5834545069527776
Current ratio: 5.184765482971761
Quick ratio: 5.184765482971761
Interest coverage ratio: -19.340378505318416
COGS to revenue (%): 51.78506784054214
R&D to revenue (%): 27.396863551456
SG&A to revenue (%): 54.017217162136724
Free cash flow (dilution-adjusted): -124788000
Buyback yield (%): 1.0685003402535131
Retained earnings: -999023000
Receivables turnover: 5.758515739003544
Capitalized R&D asset: 75680000
ROCI (R&D-adjusted, %): -12.013005015274768
FCF margin (%): -45.17441607900491
Rule of 40 score: -45.17441607900491
Financial ratios for HCAT — annual report dated 2023-12-31
Total revenue: 295938000
Gross profit: 131833000
Operating income: -99999000
Net income: -118147000
Capital expenditures: 1205000
Operating cash flow: -33080000
Depreciation & amortization: 42223000
Net tangible assets: 102883000
Owner earnings: -77129000
Return on net tangible assets (%): -74.9676817355637
Buffett classification: The Gruesome
Stock price: 9.26
Shares outstanding: 73894020
Book value: 366919000
P/B ratio: 1.8648765127998277
Market cap (USD): 684258625.1999999
Debt to equity: 0.6788092194735078
Current ratio: 4.418503043781027
Quick ratio: 4.418503043781027
Interest coverage ratio: -13.722931247426924
COGS to revenue (%): 55.45249342767742
R&D to revenue (%): 24.541289053788294
SG&A to revenue (%): 39.52922571619732
Free cash flow (dilution-adjusted): -103147000
Buyback yield (%): 0.26422757907823885
Retained earnings: -1117170000
Receivables turnover: 4.908575219771106
Capitalized R&D asset: 123332600
ROCI (R&D-adjusted, %): -10.434227951901198
Rosenberg metric: -0.017891120507399577
FCF margin (%): -34.85426001392183
Revenue growth (%): 7.1323071576478085
Rule of 40 score: -27.721952856274022
Financial ratios for HCAT — annual report dated 2024-12-31
Total revenue: 306584000
Gross profit: 140779000
Operating income: -57613000
Net income: -69502000
Capital expenditures: 1603000
Operating cash flow: 14559000
Depreciation & amortization: 41431000
Net tangible assets: 19396000
Owner earnings: -29674000
Return on net tangible assets (%): -152.99030727985152
Buffett classification: The Gruesome
Stock price: 7.07
Shares outstanding: 73894020
Book value: 365207000
P/B ratio: 1.4305057717951737
Market cap (USD): 522430721.40000004
Debt to equity: 1.1014712204311528
Current ratio: 1.4290317630811724
Quick ratio: 1.4290317630811724
Interest coverage ratio: -3.3719419407702214
COGS to revenue (%): 54.081426297523684
R&D to revenue (%): 18.901834407535944
SG&A to revenue (%): 32.294901234245756
Free cash flow (dilution-adjusted): -41967000
Buyback yield (%): 0
Retained earnings: -1186672000
Receivables turnover: 5.36154734007205
Capitalized R&D asset: 131584490
ROCI (R&D-adjusted, %): -10.29322873343522
Rosenberg metric: 0.12317733074476435
FCF margin (%): -13.688581269733579
Revenue growth (%): 3.5973751258709594
Rule of 40 score: -10.09120614386262
Financial ratios for HCAT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.07
Shares outstanding: 73894020
Market cap (USD): 522430721.40000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCAT — quarterly report dated 2025-03-31
Total revenue: 79413000
Gross profit: 36235000
Operating income: -17015000
Net income: -23742000
Capital expenditures: 663000
Operating cash flow: 280000
Depreciation & amortization: 12320000
Net tangible assets: -42969000
Owner earnings: -12085000
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 73894020
Book value: 376811000
P/B ratio: 0.8883496251436396
Market cap (USD): 334739910.6
Debt to equity: 1.0678164915567752
Current ratio: 1.244889725262913
Quick ratio: 1.244889725262913
Interest coverage ratio: -2.3257244395844725
COGS to revenue (%): 54.37145051817712
R&D to revenue (%): 19.122813645121077
SG&A to revenue (%): 32.41786609245338
Free cash flow (dilution-adjusted): -12594000
Buyback yield (%): 1.4936969992726046
Retained earnings: -1210414000
Receivables turnover: 1.2399369203385067
Capitalized R&D asset: 15186000
ROCI (R&D-adjusted, %): -1.2149860623061637
FCF margin (%): -15.858864417664615
Rule of 40 score: -15.858864417664615
Financial ratios for HCAT — quarterly report dated 2025-06-30
Total revenue: 80721000
Gross profit: 38241000
Operating income: -8325000
Net income: -40978000
Capital expenditures: 248000
Operating cash flow: -8997000
Depreciation & amortization: 12684000
Net tangible assets: -36894000
Owner earnings: -28542000
Buffett classification: The Gruesome
Stock price: 3.77
Shares outstanding: 73894020
Book value: 347547000
P/B ratio: 0.8015619625547049
Market cap (USD): 278580455.4
Debt to equity: 0.49716728960399603
Current ratio: 1.8272669317871346
Quick ratio: 1.8272669317871346
Interest coverage ratio: -1.4385692068429239
COGS to revenue (%): 52.625710781581006
R&D to revenue (%): 15.351643314626925
SG&A to revenue (%): 26.622564140682105
Free cash flow (dilution-adjusted): -22811000
Buyback yield (%): 0
Retained earnings: -1251392000
Receivables turnover: 1.1805112755564655
Capitalized R&D asset: 22566620
ROCI (R&D-adjusted, %): -0.9493318085744548
Rosenberg metric: 0.13209535098116687
FCF margin (%): -28.259065175109328
Revenue growth (%): 1.64708548978127
Rule of 40 score: -26.61197968532806
Financial ratios for HCAT — quarterly report dated 2025-09-30
Total revenue: 76323000
Gross profit: 37816000
Operating income: -17509000
Net income: -22229000
Capital expenditures: 249000
Operating cash flow: -464000
Depreciation & amortization: 12614000
Net tangible assets: -43217000
Owner earnings: -9864000
Buffett classification: The Gruesome
Stock price: 2.85
Shares outstanding: 73894020
Book value: 331923000
P/B ratio: 0.6344783488941712
Market cap (USD): 210597957
Debt to equity: 0.5185509892354552
Current ratio: 1.8812988520132434
Quick ratio: 1.8812988520132434
Interest coverage ratio: -3.107187222715173
COGS to revenue (%): 50.45268136734668
R&D to revenue (%): 16.090824522096877
SG&A to revenue (%): 39.870026073398584
Free cash flow (dilution-adjusted): -12638000
Buyback yield (%): 0
Retained earnings: -1273621000
Receivables turnover: 1.269743299672262
Capitalized R&D asset: 25595020
ROCI (R&D-adjusted, %): -3.527681845130226
Rosenberg metric: -0.03429632020658489
FCF margin (%): -16.558573431337866
Revenue growth (%): -5.448396328093062
Rule of 40 score: -22.006969759430927
Financial ratios for HCAT — quarterly report dated 2025-12-31
Total revenue: 74679000
Gross profit: 39383000
Operating income: 3261000
Net income: -91025000
Capital expenditures: 260000
Operating cash flow: 9912000
Depreciation & amortization: 12882000
Net tangible assets: -40971000
Owner earnings: -78403000
Capex to operating income (%): 7.973014412756823
Buffett classification: The Great
Stock price: 2.39
Shares outstanding: 73894020
Book value: 245780000
P/B ratio: 0.7185560574497518
Market cap (USD): 176606707.8
Debt to equity: 0.6967125071201888
Current ratio: 1.8901566320208099
Quick ratio: 1.8901566320208099
Interest coverage ratio: 0.5910821098423056
COGS to revenue (%): 47.26362163392654
R&D to revenue (%): 13.271468552069523
SG&A to revenue (%): 17.848391113967782
Free cash flow (dilution-adjusted): 209000
Buyback yield (%): 0
Retained earnings: -1364646000
Receivables turnover: 1.26300568258693
Capitalized R&D asset: 22228630
ROCI (R&D-adjusted, %): 0.377671760648546
Rosenberg metric: 0.12759547268137775
FCF margin (%): 0.2798644866696126
Revenue growth (%): -2.1540033803702685
Rule of 40 score: -1.874138893700656